-Bloomberg
OraSure Secures BARDA Funding For Next-Gen Ebola Diagnostic Test
The Biomedical Advanced Research and Development Authority (BARDA) has issued an $8.6 million contract to OraSure Technologies Inc (NASDAQ:OSUR) for developing a…
Related Posts
Replimune Group Q1 EPS $(0.53) Down From $(0.44) YoY
Replimune Group (NASDAQ:REPL) reported quarterly losses of $(0.53) per share. This is a 20.45 percent decrease over losses of $(0.44) per share from the same period last year.
Wells Fargo Maintains Equal-Weight on Juniper Networks, Raises Price Target to $30
Wells Fargo analyst Aaron Rakers maintains Juniper Networks (NYSE:JNPR) with a Equal-Weight and raises the price target from $25 to $30.